Literature DB >> 22453924

Novel mutation in spectrin-like repeat 1 of dystrophin central domain causes protein misfolding and mild Becker muscular dystrophy.

Gyula Acsadi1, Steven A Moore, Angélique Chéron, Olivier Delalande, Lindsey Bennett, William Kupsky, Mohammad El-Baba, Elisabeth Le Rumeur, Jean-François Hubert.   

Abstract

Mutations in the dystrophin gene without disruption of the reading frame often lead to Becker muscular dystrophy, but a genotype/phenotype correlation is difficult to establish. Amino acid substitutions may disrupt binding capacities of dystrophin and have a major impact on the functionality of this protein. We have identified two brothers (ages 8 and 10 years) with very mild proximal weakness, recurrent abdominal pain, and moderately elevated serum creatine kinase levels. Gene sequencing revealed a novel mutation in exon 11 of the dystrophin gene (c.1280T>C) leading to a L427P amino acid substitution in repeat 1 of the central rod domain. Immunostaining of skeletal muscle showed weak staining of the dystrophin region encoded by exons 7 and 8 corresponding to the end of the actin-binding domain 1 and the N-terminal part of hinge 1. Spectrofluorescence and circular dichroism analysis of the domain repeat 1-2 (R1-2) revealed partial misfolding of the L427P mutated protein as well as a reduced refolding rate after denaturation. Based on computational homology models of the wild-type and mutated R1-2, a molecular dynamics study showed an alteration in the flexibility of the structure, which also strongly affects the conformational space available in the N-terminal region of the fragment. Our results suggest that this missense mutation hinders the dynamic properties of the entire N-terminal region of dystrophin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453924      PMCID: PMC3365720          DOI: 10.1074/jbc.M111.284521

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  An intact cysteine-rich domain is required for dystrophin function.

Authors:  R D Bies; C T Caskey; R Fenwick
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  DMD exon 1 truncating point mutations: amelioration of phenotype by alternative translation initiation in exon 6.

Authors:  Olga L Gurvich; Baijayanta Maiti; Robert B Weiss; Gaurav Aggarwal; Michael T Howard; Kevin M Flanigan
Journal:  Hum Mutat       Date:  2009-04       Impact factor: 4.878

3.  Symptoms of upper gastrointestinal dysfunction in Duchenne muscular dystrophy: case-control study.

Authors:  K M Jaffe; C M McDonald; E Ingman; J Haas
Journal:  Arch Phys Med Rehabil       Date:  1990-09       Impact factor: 3.966

4.  Minimum folding unit of dystrophin rod domain.

Authors:  E Kahana; W B Gratzer
Journal:  Biochemistry       Date:  1995-06-27       Impact factor: 3.162

Review 5.  Dystrophin and utrophin: the missing links!

Authors:  S J Winder; T J Gibson; J Kendrick-Jones
Journal:  FEBS Lett       Date:  1995-08-01       Impact factor: 4.124

6.  The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities.

Authors:  K M Bushby; D Gardner-Medwin; L V Nicholson; M A Johnson; I D Haggerty; N J Cleghorn; J B Harris; S S Bhattacharya
Journal:  J Neurol       Date:  1993-02       Impact factor: 4.849

7.  Characterization of proline-containing alpha-helix (helix F model of bacteriorhodopsin) by molecular dynamics studies.

Authors:  R Sankararamakrishnan; S Vishveshwara
Journal:  Proteins       Date:  1993-01

8.  Upper gastrointestinal tract motility in children with progressive muscular dystrophy.

Authors:  A Staiano; E Del Giudice; A Romano; M R Andreotti; L Santoro; G Marsullo; P G Rippa; A Iovine; M Salvatore
Journal:  J Pediatr       Date:  1992-11       Impact factor: 4.406

9.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

Authors:  M Koenig; A H Beggs; M Moyer; S Scherpf; K Heindrich; T Bettecken; G Meng; C R Müller; M Lindlöf; H Kaariainen; A de la Chapellet; A Kiuru; M L Savontaus; H Gilgenkrantz; D Récan; J Chelly; J C Kaplan; A E Covone; N Archidiacono; G Romeo; S Liechti-Gailati; V Schneider; S Braga; H Moser; B T Darras; P Murphy; U Francke; J D Chen; G Morgan; M Denton; C R Greenberg; K Wrogemann; L A Blonden; M B van Paassen; G J van Ommen; L M Kunkel
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

10.  Unusual expression and very mild course of Xp21 muscular dystrophy (Becker type) in a 60-year-old man with 26 percent deletion of the dystrophin gene.

Authors:  L Palmucci; C Doriguzzi; T Mongini; G Restagno; L Chiadò-Piat; M Maniscalco
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

View more
  10 in total

1.  Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies.

Authors:  Yingyin Liang; Songlin Chen; Jianzong Zhu; Xiangxue Zhou; Chen Yang; Lu Yao; Cheng Zhang
Journal:  Bosn J Basic Med Sci       Date:  2015-05-20       Impact factor: 3.363

2.  Fine mapping of hydrophobic contacts reassesses the organization of the first three dystrophin coiled-coil repeats.

Authors:  Dominique Mias-Lucquin; Angélique Chéron; Elisabeth Le Rumeur; Jean-François Hubert; Olivier Delalande
Journal:  Protein Sci       Date:  2019-01-14       Impact factor: 6.725

3.  Functional correction of dystrophin actin binding domain mutations by genome editing.

Authors:  Viktoriia Kyrychenko; Sergii Kyrychenko; Malte Tiburcy; John M Shelton; Chengzu Long; Jay W Schneider; Wolfram-Hubertus Zimmermann; Rhonda Bassel-Duby; Eric N Olson
Journal:  JCI Insight       Date:  2017-09-21

Review 4.  Becker muscular dystrophy: case report, review of the literature, and analysis of differentially expressed hub genes.

Authors:  Min Li; Yongli Han; Shuying Wang; Yajie Yu; Mengling Liu; Yingfeng Xia; Ze'an Weng; Ling Zhou; Xiaoyan He; Jun Wang; Zhi He; Liang Yu; Yunhong Zha
Journal:  Neurol Sci       Date:  2021-11-03       Impact factor: 3.307

Review 5.  Molecular mechanisms of disease-causing missense mutations.

Authors:  Shannon Stefl; Hafumi Nishi; Marharyta Petukh; Anna R Panchenko; Emil Alexov
Journal:  J Mol Biol       Date:  2013-07-16       Impact factor: 5.469

6.  Dystrophin insufficiency causes selective muscle histopathology and loss of dystrophin-glycoprotein complex assembly in pig skeletal muscle.

Authors:  Katrin Hollinger; Cai X Yang; Robyn E Montz; Dan Nonneman; Jason W Ross; Joshua T Selsby
Journal:  FASEB J       Date:  2013-12-17       Impact factor: 5.191

7.  Missense mutation Lys18Asn in dystrophin that triggers X-linked dilated cardiomyopathy decreases protein stability, increases protein unfolding, and perturbs protein structure, but does not affect protein function.

Authors:  Surinder M Singh; Swati Bandi; Dinen D Shah; Geoffrey Armstrong; Krishna M G Mallela
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

8.  Early-progressive dilated cardiomyopathy in a family with Becker muscular dystrophy related to a novel frameshift mutation in the dystrophin gene exon 27.

Authors:  Takeshi Tsuda; Kristi Fitzgerald; Mena Scavena; Samuel Gidding; Mary O Cox; Harold Marks; Kevin M Flanigan; Steven A Moore
Journal:  J Hum Genet       Date:  2014-12-24       Impact factor: 3.172

9.  DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations.

Authors:  Jonas Juan-Mateu; Lidia Gonzalez-Quereda; Maria Jose Rodriguez; Manel Baena; Edgard Verdura; Andres Nascimento; Carlos Ortez; Montserrat Baiget; Pia Gallano
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

10.  Biallelic SYNE2 Missense Mutations Leading to Nesprin-2 Giant Hypo-Expression Are Associated with Intellectual Disability and Autism.

Authors:  Natalie Young; Maria Asif; Matthew Jackson; Daniel Martín Fernández-Mayoralas; Mar Jimenez de la Peña; Beatriz Calleja-Pérez; Sara Álvarez; Eve Hunter-Featherstone; Angelika A Noegel; Wolfgang Höhne; Peter Nürnberg; Boguslaw Obara; Muhammad Sajid Hussain; Iakowos Karakesisoglou; Alberto Fernández-Jaén
Journal:  Genes (Basel)       Date:  2021-08-24       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.